Attenuation of focal cerebral ischemic injury following post- ischemic inhibition of angiotensin converting enzyme (ACE) activity in normotensive rat

Iranian Biomedical Journal

Volumn 16, Issue 4, 2012, Pages 202-208

  Panahpour, Hamdollah ^a   Dehghani, Gholam Abbas ^b  

^a ARDABIL UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Angiotensin converting enzyme (ACE) inhibitors; Brain edema; Cerebral infarction; Enalapril

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE; ENALAPRIL;

ABSOLUTE BRAIN WATER CONTENT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN BLOOD FLOW; BRAIN EDEMA; BRAIN INFARCTION; BRAIN INFARCTION SIZE; BRAIN ISCHEMIA; BRAIN PROTECTION; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG MECHANISM; ENZYME INHIBITION; MALE; MEAN ARTERIAL PRESSURE; MIDDLE CEREBRAL ARTERY OCCLUSION; MOTOR DYSFUNCTION; NERVOUS SYSTEM PARAMETERS; NEUROLOGICAL DEFICIT SCORE; NONHUMAN; RAT; REPERFUSION INJURY; SINGLE DRUG DOSE;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; BLOOD PRESSURE; BRAIN EDEMA; BRAIN ISCHEMIA; CEREBROVASCULAR CIRCULATION; ENALAPRIL; FREE RADICALS; MALE; RATS; RATS, SPRAGUE-DAWLEY; REPERFUSION INJURY;

ANIMALIA; RATTUS;

EID: 84871809050     PISSN: 1028852X     EISSN: None     Source Type: Journal    
DOI: 10.6091/IBJ.1096.2012     Document Type: Article

References (32)

1. Dirnagl U, C Iadecola, MA Moskowitz. Pathobiology of ischaemic stroke: an integrated view. Trends Neurosci. 1999 Sep;22(9):391-7.
2. Jones TH, Morawetz RB, Crowell RM, Marcoux FW, FitzGibbon SJ, DeGirolami U et al. Thresholds of focal cerebral ischemia in awake monkeys. J Neurosurg. 1981 Jun;54(6):773-82.
3. Schuier FJ, Hossmann KA. Experimental brain infarcts in cats. II. Ischemic brain edema. Stroke. 1980 Nov-Dec;11(6):593-601.
4. Panahpour H, Nekooeian AA, Dehghani GA. Inhibition of angiotensin-converting enzyme reduces cerebral infarction size in experimental-induced focal cerebral ischemia in the rat. Iran J Med Sci. 2007 Mar.32(1):12-7.
5. Unger T, Badoer E, Ganten D, Lang R, Rettig R. Brain angiotensin: pathways and pharmacology. Circulation. 1988 Jun;77(6 Pt 2):I40-54.
6. Culman J, Blume A, Gohlke P, Unger T. The reninangiotensin system in the brain: possible therapeutic implications for AT(1)-receptor blockers. J Hum Hypertens. 2002 Aug;16Suppl 3:S64-70.
7. Brdon J, Kaiser S, Hagemann F, Zhao Y, Culman J, Gohlke P. Comparison between early and delayed systemic treatment with candesartan of rats after ischaemic stroke. J Hypertens. 2007 Jan;25(1):187-96.
8. Ito T, Yamakawa H, Bregonzio C, Terrón JA, Falcón-Neri A, JM Saavedra. Protection against ischemia and improvement of cerebral blood flow in genetically hypertensive rats by chronic pretreatment with an angiotensin II AT1 antagonist. Stroke. 2002 Sep;33(9): 2297-303.
9. Mohammadi MT, Shid-Moosavi SM, Dehghani GA, Contribution of nitric oxide synthase (NOS) in bloodbrain barrier disruption during acute focal cerebral ischemia in normal rat. Pathophysiology. 2012 Feb;19 (1):13-20.
10. Longa EZ, Weinstein PR, Carlson S, Cummins R. Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke. 1989 Jan;20(1)84-91.
11. Panahpour H, Dehghani GA. Inhibition of central angiotensin-converting enzyme with enalapril protects the brain from ischemia/reperfusion injury in normotensive rat. Daru. 2010;18(1):35-40.
12. Vakili A, Nekooeian A, Dehghani GA. Aminoguanidine reduces infarct volume and improves neurological dysfunction in transient model of focal cerebral ischemia in rat. DARU. 2006. 14(1):26-30.
13. Gerriets T, Stolz E, Walberer M, Muller C, Kluge A, Bachmann A, et al. Noninvasive quantification of brain edema and the space-occupying effect in rat stroke models using magnetic resonance imaging. Stroke. 2004 Feb;35(2):566-71.
14. Mohammadi MT, Shid Moosavi SM, Dehghani GA. Contribution of nitric oxide synthase (NOS) activity in blood-brain barrier disruption and edema after acute ischemia/reperfusion in aortic coarctation-induced hypertensive rats. Iran Biomed J. 2011;15(1-2):22-30.
15. Ferrari R, Cargnoni A, Curello S, Ceconi C, Boraso A, Visioli O. Protection of the ischemic myocardium by the converting-enzyme inhibitor zofenopril: insight into its mechanism of action. J Cardiovasc Pharmacol. 1992;19(5):694-704.
16. Kohara K, Mikami H, Okuda N, Higaki J, Ogihara T. Angiotensin blockade and the progression of renal damage in the spontaneously hypertensive rat. Hypertension. 1993 Jun;21(6 Pt2):975-9.
17. Ravati A, Junker V, Kouklei M, Ahlemeyer B, Culmsee C, Krieglstein J. Enalapril and moexipril protect from free radical-induced neuronal damage in vitro and reduce ischemic brain injury in mice and rats. Eur J Pharmacol. 1999 May;373(1):21-33.
18. Groth W, Blume A, Gohlke P, Unger T, Culman J. Chronic pretreatment with candesartan improves recovery from focal cerebral ischaemia in rats. J Hypertens. 2003 Nov;21(11):2175-82.
19. Shima T, Hossmann K, Date H. Pial arterial pressure in cats following middle cerebral artery occlusion. Relationship to blood flow, regulation of blood flow and electrophysiological function. Stroke. 1983 Sep-Oct;14 (5):713-9.
20. Dzau VJ. Vascular renin-angiotensin system in hypertension. New insights into the mechanism of action of angiotensin converting enzyme inhibitors. Am J Med. 1988 Apr;84(4A):4-8.
21. Haas DC, Anderson GH Jr, Streeten DH. Role of angiotensin in lethal cerebral hypoperfusion during treatment of acute hypertension. Arch Intern Med. 1985 Oct;145(10)1922-4.
22. Speth RC, Harik SI. Angiotensin II receptor binding sites in brain microvessels. Proc Natl Acad Sci USA. 1985 Sep;82(18):6340-3.
23. Chan PH, Kawase M, Murakami K, Chen SF, Li Y, Calaqui B, et al., Overexpression of SOD1 in transgenic rats protects vulnerable neurons against ischemic damage after global cerebral ischemia and reperfusion. J Neurosci. 1998 Oct;18(20):8292-9.
24. Kinouchi H, Epstein CJ, Mizui T, Carlson E, Chen SF, Chan PH. Attenuation of focal cerebral ischemic injury in transgenic mice overexpressing CuZn superoxide dismutase. Proc Natl Acad Sci USA. 1991 Dec;88(24): 11158-62.
25. Sugawara T, Kinouchi H, Oda M, Shoji H, Omae T, Mizoi K. Candesartan reduces superoxide production after global cerebral ischemia. Neuroreport. 2005 Mar. 16(4):325-8.
26. 2+ and BBB permeability and ultrastructure in head injury with secondary insult. J Clin Neuroscience. 2001 Nov.8(6):561-3.
27. Stier C, Benter IF, Ahmad S, Zuo H, Selig N, Roethel S et al. Enalapril prevents stroke and kidney dysfunction in salt-loaded stroke-prone spontaneously hypertensive rats. Hypertension. 1989 Feb.13(2):115-21.
28. Stier C Jr, Chander P, Gutstein W, Levine S, Itskovitz H. Therapeutic benefit of captopril in salt-loaded strokeprone spontaneously hypertensive rats is independent of hypotensive effect. Am J Hypertens. 1991 Aug;4(8):680-7.
29. Vacher E, Fornes P, Domergue V, Richer C, Bruneval P, Giudicelli JF. Quinapril prevents stroke both during and after the treatment period in stroke-prone spontaneously hypertensive rats. Am J Hypertens. 1993 Nov;6(11 Pt 1):951-9.
30. Inada Y, Ojima M, Itoh K, Shino A, Nishikawa K. Effects of delapril on stroke, kidney dysfunction and cardiac hypertrophy in stroke-prone spontaneously hypertensive rats. Drugs Exp Clin Res. 1995;21(2):41-9.
31. Blezer ELA, Nicolay K, Koomans HA, Joles JA. Losartan versus enalapril on cerebral edema and proteinuria in stroke-prone hypertensive rats. Am J Hypertens. 2001 Jan;14(1):54-61.
32. Porritt MJ, Chen M, Rewell SSJ, Dean RG, Burrell LM. Howells DW, ACE inhibition reduces infarction in normotensive but not hypertensive rats: correlation with cortical ACE activity. J Cereb Blood Flow Metab. 2010 Aug;30(8:1520-6.